Asbestos-related Diseases / / edited by Takemi Otsuki.
The issue of asbestos exposure and the resulting health problems is now a global problem. The World Health Organization (WHO) has made recommendations on the eradication of asbestos-related diseases. However, malignant mesothelioma, mainly due to asbestos exposure, is a refractory malignant tumor, a...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London, England : : IntechOpen,, 2020. |
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 online resource (80 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603129704498 |
---|---|
ctrlnum |
(CKB)5400000000040660 (NjHacI)995400000000040660 (EXLCZ)995400000000040660 |
collection |
bib_alma |
record_format |
marc |
spelling |
Asbestos-related Diseases / edited by Takemi Otsuki. London, England : IntechOpen, 2020. 1 online resource (80 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. The issue of asbestos exposure and the resulting health problems is now a global problem. The World Health Organization (WHO) has made recommendations on the eradication of asbestos-related diseases. However, malignant mesothelioma, mainly due to asbestos exposure, is a refractory malignant tumor, and technological innovation in diagnosis and treatment is required. In this context, this book describes the immunological effects of asbestos exposure, blood biomarkers, the pathology of malignant mesothelioma, and the status of immune checkpoint drugs in the treatment of malignant mesothelioma, along with the status of MMP mesothelioma. Concerns about health hazards associated with asbestos exposure may persist for many years to come. We hope this book will help researchers in this area. Asbestos Health aspects. Asbestos Toxicology. 1-83880-834-5 Otsuki, Takemi, editor. |
language |
English |
format |
eBook |
author2 |
Otsuki, Takemi, |
author_facet |
Otsuki, Takemi, |
author2_variant |
t o to |
author2_role |
TeilnehmendeR |
title |
Asbestos-related Diseases / |
spellingShingle |
Asbestos-related Diseases / |
title_full |
Asbestos-related Diseases / edited by Takemi Otsuki. |
title_fullStr |
Asbestos-related Diseases / edited by Takemi Otsuki. |
title_full_unstemmed |
Asbestos-related Diseases / edited by Takemi Otsuki. |
title_auth |
Asbestos-related Diseases / |
title_new |
Asbestos-related Diseases / |
title_sort |
asbestos-related diseases / |
publisher |
IntechOpen, |
publishDate |
2020 |
physical |
1 online resource (80 pages) |
isbn |
1-83880-834-5 |
callnumber-first |
R - Medicine |
callnumber-subject |
RA - Public Medicine |
callnumber-label |
RA1231 |
callnumber-sort |
RA 41231 A8 A834 42020 |
illustrated |
Not Illustrated |
dewey-hundreds |
300 - Social sciences |
dewey-tens |
360 - Social problems & social services |
dewey-ones |
363 - Other social problems & services |
dewey-full |
363.1791 |
dewey-sort |
3363.1791 |
dewey-raw |
363.1791 |
dewey-search |
363.1791 |
work_keys_str_mv |
AT otsukitakemi asbestosrelateddiseases |
status_str |
n |
ids_txt_mv |
(CKB)5400000000040660 (NjHacI)995400000000040660 (EXLCZ)995400000000040660 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Asbestos-related Diseases / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653201762549761 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01747nam a2200301 i 4500</leader><controlfield tag="001">993603129704498</controlfield><controlfield tag="005">20230623121547.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230623s2020 enk o 000 0 eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.5772/intechopen.83098</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040660</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000040660</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040660</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA1231.A8</subfield><subfield code="b">.A834 2020</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">363.1791</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Asbestos-related Diseases /</subfield><subfield code="c">edited by Takemi Otsuki.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (80 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The issue of asbestos exposure and the resulting health problems is now a global problem. The World Health Organization (WHO) has made recommendations on the eradication of asbestos-related diseases. However, malignant mesothelioma, mainly due to asbestos exposure, is a refractory malignant tumor, and technological innovation in diagnosis and treatment is required. In this context, this book describes the immunological effects of asbestos exposure, blood biomarkers, the pathology of malignant mesothelioma, and the status of immune checkpoint drugs in the treatment of malignant mesothelioma, along with the status of MMP mesothelioma. Concerns about health hazards associated with asbestos exposure may persist for many years to come. We hope this book will help researchers in this area.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Asbestos</subfield><subfield code="x">Health aspects.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Asbestos</subfield><subfield code="x">Toxicology.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83880-834-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otsuki, Takemi,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:15:22 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337909390004498&Force_direct=true</subfield><subfield code="Z">5337909390004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337909390004498</subfield></datafield></record></collection> |